1-3 of 3
Peter R. E. Johnson, MD
Close
Sort by
Journal Articles

BEAM-Campath Allogeneic Stem Cell Transplantation for Aggressive Non-Hodgkin's Lymphomas. An Analysis of Outcomes From the BSBMT

Stephen Robinson, MBBS, MRCP, FRCPath, PhD, Christopher P Fox, MBChB, MRCP, FRCPath, Rachel M Pearce, Julia Perry, Keiren Kirkland, Charles F. Craddock, BM, MRCP, MRCPath, Nigel H Russell, MD, Grant McQuaker, MD, Antonio Pagliuca, Peter R. E. Johnson, MD, Gordon Cook, MD PhD
Journal: Blood
Blood (2012) 120 (21): 2039.
https://doi.org/10.1182/blood.V120.21.2039.2039
Published: 2012
Journal Articles

Autologous Stem Cell Transplantation (ASCT) for Enteropathy-Associated T-Cell Lymphoma (EATL): Final Analysis of a Retrospective Study On the Behalf of Lymphoma Working Party (LWP) of the European Group for Blood and Marrow Transplantation (EBMT).

Esa Jantunen, Ariane Boumendil, Herve Finel, Jian Jian Luan, Peter R. E. Johnson, MD, Alessandro Rambaldi, MD, Andrew Haynes, Michel A. Duchosal, MD, Lothar Kanz, MD, Pierre Biron, Kristina Carlsson, Charles Craddock, Claudius Rudin, Jurgen Finke, MD, Gilles Salles, MD, Peter Dreger, MD, Anna Sureda, MD
Journal: Blood
Blood (2012) 120 (21): 3105.
https://doi.org/10.1182/blood.V120.21.3105.3105
Published: 2012
Journal Articles

Lenalidomide Enhances Leukaemia Specific T Cell Responses to Dendritic Cell Based Immunotherapy for Myeloid Leukaemias.

Caroline J Duncan, MBBS, MRCP(Ed), Peter R. E. Johnson, MD, Huw Roddie, MBChB, PhD
Journal: Blood
Blood (2008) 112 (11): 1954.
https://doi.org/10.1182/blood.V112.11.1954.1954
Published: 2008